🇨🇭 Partnership

ACROSS Global Connect Alliance

Unified clinical trial infrastructure across 90+ countries

Global clinical trials require coordination across multiple countries, vendors, and systems. By implementing a unified Clinical Research Information System (CRIS), ACROSS Global Connect Alliance reduces fragmentation, improves data consistency, and enables scalable execution across multi-country studies.

90+
countries
20+
global partners
Unified
clinical trial infrastructure
25+
therapy areas

About the Alliance

About ACROSS Global Connect Alliance

Across Global Connect Alliance is a Singapore-based strategic network of clinical research organizations (CROs) and specialist service providers (SSPs) operating across more than 90 countries.

Wemedoo partnered with ACROSS Global Connect Alliance to implement oomnia as its centralized clinical trial infrastructure, creating a unified digital environment across the entire network.

About Across Global Connect Alliance
ACROSS Global Connect Alliance CRO network partner logo

Global Reach

ACROSS Global Connect Alliance spans 90+ countries

90+ countries
20+ global partners
Unified clinical trial infrastructure
25+ therapy areas

Alliance Value Proposition

The ACROSS Global advantages

  • Dedicated alliance network manager
  • Joining a network with global reach
  • Central orchestration & client contracting
  • Sole ownership of your market
  • One central e-clinical platform
  • Pro-active marketing across multiple platforms
  • Profit pool & attractive referral fee commission
  • Central quality management / SOPs
  • Prestige associated with partner membership
  • Expand globally immediately

Leadership Perspective

Leading with purpose and data

The power of trust-driven teams

Running global clinical trials requires a system that facilitates seamless collaboration, eliminates unnecessary delays, and ensures data consistency across all sites. With oomnia, we have found a platform that meets these demands while maintaining compliance and operational flexibility.
Steven Bukvic
Managing Director of Across Global Connect Alliance

The Platform

Centralized clinical trial infrastructure powered by oomnia

Through this partnership, oomnia serves as the digital backbone of the Across Global Connect Alliance, connecting teams, workflows, and data across all regions. This establishes a standardized, scalable, and globally aligned foundation for executing multi-country clinical trials within a single unified environment.

Explore oomnia

Unified clinical trial systems: EDC, CTMS, RTSM, eTMF

By unifying essential clinical trial systems within oomnia, the alliance benefits from:

  • Consistent trial execution across regions
  • Real-time collaboration among alliance members
  • Improved data integrity and centralized oversight
  • Reduced operational complexity

EDC, CTMS, RTSM, and eTMF operate within a shared data model, eliminating fragmentation and reducing manual handoffs.

Improved collaboration, data quality, and operational efficiency

With unified data and workflows, the alliance achieves:

  • Faster and clearer cross-regional communication
  • Improved data accuracy through standardized processes
  • Reduced administrative overhead across sites and teams
  • Greater transparency and control across global studies

This directly enhances trial quality and decision-making efficiency.

A unified approach to scalable global clinical studies

Powered by oomnia, the ACROSS Global Connect Alliance strengthens coordination across global clinical studies while supporting:

  • Flexibility for different study designs and operational models
  • Scalability across small, mid-size, and large multi-regional trials
  • Reduced operational complexity across multi-vendor environments

This partnership reflects a shared vision: connected systems, aligned teams, and scalable global clinical trial delivery.

Supporting compliant global clinical trials

oomnia enables the ACROSS Global Connect Alliance to conduct multi-country clinical trials while maintaining regulatory alignment and operational flexibility. This includes:

  • Support for diverse regional regulatory requirements
  • Alignment with GxP principles and ICH-GCP guidelines
  • 21 CFR Part 11–compliant electronic records and signatures
  • GDPR-aligned data protection practices

This ensures trials remain compliant, scalable, and inspection-ready across regions.

Partner with us

Build global clinical trial partnerships with unified technology

Wemedoo partners with CRO networks, sponsors, and clinical research organizations to deliver unified clinical trial infrastructure across regions and study types.

See how unified clinical trial software can support your organization across partners, countries, and complex study environments.

Start a partnership

Frequently asked questions (FAQ)

What is the ACROSS Global Connect Alliance?

ACROSS Global Connect Alliance is a Singapore-based strategic network of CROs and specialist service providers operating across more than 90 countries, enabling coordinated execution of global clinical trials.

Why did ACROSS Global Connect Alliance partner with Wemedoo?

ACROSS Global Connect Alliance selected Wemedoo to implement a unified clinical trial infrastructure that reduces system fragmentation and enables consistent, scalable execution across its global network.

How does a unified CRIS support ACROSS Global Connect Alliance's global operations?

By centralizing clinical trial data, workflows, and systems within one platform, the unified CRIS allows ACROSS Global Connect Alliance to standardize trial execution while maintaining flexibility across regions.

How does the partnership improve collaboration across countries and partners?

The shared platform enables real-time collaboration, standardized processes, and centralized oversight, improving communication between alliance members, sponsors, and study sites worldwide.

Does the platform support global regulatory requirements?

Yes. The unified infrastructure supports compliance with global and regional regulatory standards, including ICH-GCP, GxP principles, 21 CFR Part 11, and GDPR-aligned data protection practices.

What types of studies benefit most from this partnership?

Multi-country and multi-regional clinical studies benefit most, particularly those requiring standardized execution, strong coordination across vendors, and centralized oversight.